Precision Medicine

By Jessica Davis 10:30 am August 09, 2016
The university aims to make genetic testing a regular part of healthcare using Google's Cloud Platform and informatics.
NIH Allscripts precision medicine
By Bernie Monegain 10:03 am August 09, 2016
Doctors at the National Human Genome Research Institute, the National Cancer Institute and the NIH Clinical Center will use the tools to combine genomic and clinical data for statistical analysis and pattern detection.
IBM Watson leukemia
By Bernie Monegain 10:58 am August 08, 2016
The supercomputer identified a different type of cancer than the one doctors were currently treating for a patient in Japan.
Johns Hopkins EpiWatch Apple
By Jack McCarthy 10:17 am August 05, 2016
The software currently enables people living with epilepsy to track their seizures and researchers want to develop the program into a seizure detector as well.
IBM lab on a chip
By Bernie Monegain 09:40 am August 04, 2016
The company also said its scientists are working with Icahn School of Medicine at Mount Sinai to test the technology on prostate cancer.
Michigan Obama Precision Medicine
By Jack McCarthy 03:44 pm August 01, 2016
The U-M School of Public Health will collaborate with Vanderbilt University’s Data and Research Support Center to organize and analyze data for the effort. 
Precision medicine
By Jack McCarthy 10:20 am July 29, 2016
Cancer treatments, drug discovery, genome sequencing, president Obama’s Precision Medicine Initiative, are all driving big spending for personalized and precision medicine. 
NantHealth Utah precision medicine
By Bernie Monegain 12:41 pm July 26, 2016
The organizations kick off a project to recruit 1,000 people for whole genome sequencing using the NantHealth platform and the university's population health database.
By Kaiser Health News 11:01 am July 21, 2016
Researchers in California regularly use a database to search for trends, confirm potential cancer clusters and identify disparities in screening and outcomes.
By Bernie Monegain 10:40 am July 21, 2016
Scientists at Weill Cornell Medicine say the new genome sequencing test to detect mutations can guide precision cancer treatment with more than 95 percent accuracy.